23.12.2020 04:05:44
|
Walmart Accused Of Fueling Opioid Crisis In U.S.
(RTTNews) - The U.S. Department of Justice filed a lawsuit against Walmart alleging that the company unlawfully dispensed controlled substances through its pharmacies and fueled the opioid crisis. It seeks civil penalties that could total in the billions of dollars.
Responding to the lawsuit, Walmart said that the Justice Department's investigation is tainted by historical ethics violations, and the lawsuit invents a legal theory that unlawfully forces pharmacists to come between patients and their doctors.
Walmart also alleged that the lawsuit is riddled with factual inaccuracies and cherry-picked documents taken out of context.
The Justice Department's complaint, which was filed in the U.S. District Court for the District of Delaware, alleged that as the operator of its pharmacies, Walmart knowingly filled thousands of controlled substance prescriptions that were not issued for legitimate medical purposes or in the usual course of medical practice, and that it filled prescriptions outside the ordinary course of pharmacy practice.
The complaint also alleged that as the operator of its distribution centers, Walmart received hundreds of thousands of suspicious orders that it failed to report as required to by the U.S. Drug Enforcement Administration.
Therefore, the complaint said that the unlawful conduct resulted in hundreds of thousands of violations of the Controlled Substances Act. It seeks civil penalties, which could total in the billions of dollars, and injunctive relief.
If Walmart is found liable for violating the rule, it could face civil penalties of up to $67,627 for each unlawful prescription filled and $15,691 for each suspicious order not reported. The court also may award injunctive relief to prevent Walmart from committing further violations of the Controlled Substances Act.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Walmartmehr Nachrichten
28.02.25 |
Handel in New York: Dow Jones verbucht am Nachmittag Zuschläge (finanzen.at) | |
28.02.25 |
NYSE-Handel: Dow Jones-Anleger greifen zum Handelsstart zu (finanzen.at) | |
26.02.25 |
Dow Jones 30 Industrial-Wert Walmart-Aktie: So viel Gewinn hätte eine Walmart-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
25.02.25 |
Dow Jones aktuell: Dow Jones liegt zum Handelsende im Plus (finanzen.at) | |
25.02.25 |
Börse New York: Dow Jones bewegt sich nachmittags im Plus (finanzen.at) | |
25.02.25 |
Anleger warten auf Impulse: Dow Jones notiert mittags um Vortagesschluss (finanzen.at) | |
25.02.25 |
Dienstagshandel in New York: Dow Jones präsentiert sich zum Start des Dienstagshandels leichter (finanzen.at) | |
24.02.25 |
Börse New York: Dow Jones verbucht zum Ende des Montagshandels Gewinne (finanzen.at) |
Analysen zu Walmartmehr Analysen
24.02.25 | Walmart Kaufen | DZ BANK | |
21.02.25 | Walmart Buy | UBS AG | |
21.02.25 | Walmart Overweight | JP Morgan Chase & Co. | |
21.02.25 | Walmart Outperform | RBC Capital Markets | |
20.02.25 | Walmart Buy | UBS AG |
Aktien in diesem Artikel
Walmart | 87,80 | -1,35% |
|